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ABSTRACT  22 
Frontometaphyseal dysplasia 2 (FMD2) is a skeletal dysplasia with supraorbital hyperostosis 23 
combined with undermodeling of the bones, joint contractures and some extraskeletal features. 24 
It is caused by heterozygous mutations in MAP3K7, encoding the Mitogen-Activated Protein 3-25 
Kinase 7. MAP3K7 is activated by TGF-β and plays an important role in osteogenesis. Less than 20 26 
patients with FMD2 and MAP3K7 mutations have been described thus far. The majority of the 27 
patients harbor a recurrent missense mutation, NM_003188.3: c.1454C>T [NP_003179.1: 28 
p.(Pro485Leu)], which leads to a more severe phenotype than mutations in other domains. Here 29 
we describe an additional patient with FMD2 caused by the recurrent c.1454C>T MAP3K7 30 
mutation, identified as a de novo variant by whole-genome sequencing. The 17-year-old boy has 31 
the characteristic skeletal and facial features of FMD2. However, some novel features were also 32 
observed, including growth retardation and spina bifida occulta. In line with other patients 33 
harboring the same mutation he also showed keloid scars and had no intellectual disability. This 34 
report expands the clinical spectrum of FMD2 caused by the recurrent c.1454C>T [p.(Pro485Leu)] 35 
mutation in MAP3K7. 36 
 37 




















1 INTRODUCTION 41 
Skeletal dysplasias constitute a large and heterogeneous group of disorders characterized by a 42 
broad phenotypic and genetic variability (Bonafe et al., 2015). Short stature is the main hallmark 43 
but many other features, including deformities and extra-skeletal manifestations, may also be 44 
present. Abnormalities in signaling pathways crucial for the growth plate, i.e. Notch, WNT, FGF, 45 
Hedgehog, and BMP pathways, are common causes of skeletal dysplasias (Geister and Camper, 46 
2015).  47 
Recently, heterozygous disease-causing mutations in MAP3K7, encoding the Mitogen-Activated 48 
Protein Kinase 7 (also known as TAK1), were described in Frontometaphyseal dysplasia 2 (FMD2) 49 
in less than 20 patients (Wade et al., 2016; Wade et al., 2017). This kinase is stimulated by TGF-β 50 
and BMPs and plays an important role in the NF-κB signaling and is consequently a key regulator 51 
of osteogenesis (Thouverey and Caverzasio, 2012).  52 
Phenotypically, patients with FMD2 are very similar to patients with frontometaphyseal dysplasia 53 
1 (FMD1), caused instead by mutations in FLNA (Robertson et al., 2003). The shared clinical 54 
characteristics include sclerosis of the skull and long bones, prominent supraorbital ridges and 55 
abnormal fingers. Some patients also present with extra-skeletal manifestations, such as hearing 56 
loss, urogenital problems and joint contractures (Wade et al., 2016). In addition, patients with 57 
FMD2 also seem to have a predisposition to keloid scars, especially if they are females (Wade et 58 
al., 2017).  59 
In some aspects, patients with FMD2 also resemble patients with cardiospondylocarpofacial 60 


















syndrome is characterized by distinct phenotypic features such as growth retardation, 62 
brachydactyly, short limbs and joint laxity (Le Goff et al., 2016). 63 
Here we describe a 17-year-old male with FMD2 caused by the recurrent missense mutation 64 
NM_003188.3: c.1454C>T [NP_003179.1: p.(Pro485Leu)] in MAP3K7 and presenting with several 65 
novel phenotypic manifestations. 66 
2 CLINICAL REPORT 67 
2.1 Clinical manifestations 68 
The index patient and his healthy parents were recruited at the Folkhälsan Department of 69 
Medical Genetics to a research project exploring genetic causes of skeletal dysplasia. The study 70 
protocol was approved by the Research Ethics Board at Helsinki University Hospital and informed 71 
consents were obtained from the participants prior to the study.  72 
The patient, a boy born to non-consanguineous Finnish parents, presented at birth with tetralogy 73 
of Fallot, a clavicular fracture, ulnar deviation of the wrists, contractures of the elbows, pes 74 
metatarsovarus, and hydronephrosis due to ureteral reflux (Table 1). The skull was somewhat 75 
dolichocephalic with a sloping forehead, the fontanelle was large, and vertebrae C3 and C4 had 76 
reduced height. The fingers and toes were long, with broad distal phalanges of the fingers. His 77 
birth weight, length and head circumference (3680g / 51cm / 35.5 cm) were normal, and he 78 
received 9 Apgar points.  79 
His slight dysmorphic features included hypertelorism, down-slanting palpebral fissures, broad 80 


















single palmar creases and camptodactyly in both hands. Hemangiomas were present on the 82 
forehead and the occiput 83 
and the neck. He was treated with von Rosen’s cast for hip dysplasia and joint contractures and 84 
underwent corrective cardiac surgery at the age of 6 months. 85 
On examination at age 1 year, in addition to the above-mentioned dysmorphic features, he was 86 
noted to have colobomas of the nostrils. Freeman-Sheldon syndrome was suspected. At the age 87 
of 3 years, he was observed to have a submucosal cleft palate and a hearing deficit requiring 88 
hearing aids.  89 
At 6 years, the boy was found to have a craniocervical malformation (a sharp angle between the 90 
clivus and the dens, and caudal displacement of the conus) in combination with Chiari I-91 
malformation. He underwent occipito-cervical fusion to stabilize his neck (Fig. 1). Decompression 92 
of the foramen magnum was performed during the same operation because of the Chiari I 93 
malformation. He was found to have spina bifida occulta in several vertebrae and bilateral 94 
Sprengel deformities. The Halo bracing, used for stabilization, caused severe keloid formation in 95 
his back (Fig. 1D). He also underwent surgery for unilateral cryptorchidism. His orbital ridges were 96 
increasingly prominent (Fig. 1A-B) and a corrective surgery was performed at 11 years to flatten 97 
the protruding bony parts of the forehead. 98 
The patient had always been sensitive to light but initial examinations revealed no etiology. At 99 
the age of 6, he was found to have subepithelial corneal scarring (leucoma corneae), astigmatism, 100 


















At 7 years, he had short stature (-1.5 SD) (Supplemental Fig. S1), scoliosis (Fig. 1C), slightly weak 102 
voice, and mild atopy, and was prone to infections. Intellectual development and school 103 
performance were normal.  104 
His growth, which decelerated already starting from 3-4 years of age when scoliosis was not 105 
present, has progressed slowly despite normal pubertal development (Supplemental Fig. S1).  By 106 
age 17 years, his scoliosis has significantly progressed (Cobb’s angle 42°) and may partly explain 107 
the lack of pubertal growth spurt and his severe height deficit (148 cm; -4.3 SDS). He has flexion 108 
contractures in the knees, hips and elbows and his feet are deformed and rigid.   109 
2.2 Genetic findings  110 
In order to identify the genetic cause in our index patient, we performed whole-genome 111 
sequencing (WGS) on the trio. Pair-end sequencing (2x150 bp) was performed at the SciLifeLab 112 
(Stockholm) on the HiSeqX instrument (Illumina), with an average coverage of 30X. Read 113 
alignment to the human genome assembly (GRCh37) was performed with the Burrow-Wheeler 114 
Aligner (BWA); data processing and variant calling were carried out using Genome Analysis Toolkit 115 
(GATK). Variants were annotated using Variant Effect Predictor (VEP) and data analysed using 116 
GEMINI. Candidate gene variants were filtered using a MAF < 0.001 in GnomAD and SweGen 117 
databases and assuming autosomal recessive/compound heterozygous inheritance pattern or a 118 
de novo variant (Ameur et al., 2017). Furthermore, we chose the impact severity of the variant to 119 
be different than “low” in GEMINI. Findings were validated by Sanger sequencing.  120 
Whole-genome sequencing in our trio led to the identification of two heterozygous candidate 121 
genetic variants in the index patient, both identified as de novo: 1) a recurrent missense variant 122 


















2) a novel missense variant NM_020120.3: c.152C>T [NP_064505.1: p.(Leu51Pro)] in UGGT1, 124 
encoding the UDP-Glucose Glycoprotein Glucosyltransferase 1. UGGT1 is involved in the quality 125 
control of protein folding in the endoplasmic reticulum (Arnold et al., 2000). However, mutations 126 
in this gene have not been associated with any disease yet. On the other hand, mutations in 127 
MAP3K7 have been described in two skeletal diseases: FMD2 and cardiospondylocarpofacial 128 
syndrome. Based on previous studies and phenotypic correlations, the variant in MAP3K7 was 129 
regarded as the cause of our patient’s disorder, confirming a diagnosis of FMD2. This finding, 130 
which was also validated with Sanger sequencing (Supplemental Fig. S2B-S2D), allowed us to re-131 
evaluate our patient’s clinical features and compare with previously reported patients with the 132 
same recurrent p.(Pro485Leu) mutation in MAP3K7. 133 
3. DISCUSSION  134 
Our patient had many features in common with the previously reported patients, including 135 
prominent supraorbital ridges, hypertelorism, down-slanting palpebral fissures, broad nasal 136 
bridge, full cheeks, micrognathia, hydronephrosis, cleft palate, hearing loss, scoliosis, ulnar 137 
deviation of the hands, camptodactyly, wrist contractures, long fingers, structural cardiac defect 138 
and keloid scars (Table 1, Fig. 1) (Basart et al., 2015; Morava et al., 2003; Wade et al., 2016; Wade 139 
et al., 2017). Radiologically, he had a craniocervical malformation, Chiari I-malformation as well as 140 
progressive scoliosis requiring surgery, and dislocated and abnormally shaped radial heads.  141 
He did not have valgus but varus deformity of the feet and he had normal intellect. Moreover, he 142 
had some features not previously noted in patients with the same mutation: significant growth 143 
retardation, only partly explained by scoliosis, resulting in severe short stature (height -4.3 SDS at 144 


















single palmar creases, pes cavus, and amblyopia. Amblyopia is common in the general population 146 
and it might be a coincidental finding in our patient. Furthermore, Chiari I malformation, Sprengel 147 
deformity and single palmar creases are similar to contractures and skeletal deformities 148 
described in other individuals with FMD (Basart et al., 2015; Robertson et al., 2003; Wade et al., 149 
2016; Wade et al., 2017). In line with this, spina bifida occulta is part of the cervical spine 150 
dysraphism in FMD but it has never been reported hitherto in patients with MAP3K7 mutations. 151 
Finally, leucoma corneae and astigmatism were observed previously in one patient with a 152 
MAP3K7 mutation (Basart et al., 2015), suggesting that this feature may be a part of the 153 
phenotypic spectrum of FMD2.  154 
The majority of the patients hitherto reported as having FMD2 harbor the same recurrent 155 
mutation as the one identified in our patient, c.1454C>T [p.(Pro485Leu)]. This mutation affects 156 
the TAB2 domain of the protein (Table 1; Supplemental Fig.S3) (Wade et al., 2016; Wade et al., 157 
2017). Only 3 patients have been described as having other missense mutations (Wade et al., 158 
2016; Wade et al., 2017). These mutations cluster closer to the N-terminal, in the tyrosine kinase 159 
domain, and give rise to milder phenotypes than the ones caused by the recurrent mutation 160 
(Table 1; Supplemental Fig.S3). Although the majority of features in our patient overlap with the 161 
ones previously described in other FMD2 patients, his phenotype also includes some novel 162 
features (Table 1). For example, short stature has not been previously reported in FMD2. 163 
However, short stature is one of the hallmarks of patients with cardiospondylocarpofacial 164 
syndrome, which is also caused by MAP3K7 mutations (Le Goff et al., 2016). Furthermore, our 165 
patient has additional hand and foot deformities as well as spina bifida occulta, vision problems, 166 
undescended testis and hemangiomas that have not previously been described in other patients 167 


















In summary, our detailed report corroborates many of the clinical features previously described 169 
in patients with FMD2 caused by the recurrent MAP3K7 mutation c.1454C>T [p.(Pro485Leu)] but 170 
also describes some novel or unusual characteristics, in particular growth retardation, which may 171 
suggest a partial overlap between FMD2 and cardiospondylocarpofacial syndrome.  172 
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FIGURE LEGENDS 242 
Figure 1.  At 11 years the patient had significant supraorbital hyperostosis (A), as seen also in the 243 
preoperative CT at 11 years (B). He required hearing aids for hearing deficit, had atopic eczema 244 
and abnormal scapulae (A). He underwent occipito-cervical fusion to stabilize the neck at 6 years 245 
and had by 8 years developed significant scoliosis (C). Halo bracing resulted in keloid formation in 246 
the back (D). Radiograph of the pelvis and hips at 3 years (E) showed dysplastic hips and coxa 247 
valga. Hand radiograph at 16 years (F) showed undertubulation of the digital bones. Cavovarus 248 














Table 1. Summary of the clinical features in the 19 thus far reported index patients with FMD2 due to MAP3K7 mutations. Mutations 
are given as amino acid changes. The novel or unusual clinical features in our patient are marked in blue text. Colours indicate 
features that were present (yellow), absent (dark blue) or unknown (grey) in the patients. F= female; M=male; D= deceased. 
  This 
report 
Basart et al. 2015; Wade et al. 2016; Wade et al. 2017 
 Individual 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
 Sex M M M M M M M M M F F F F F F F F F F 
 Age at last assessment 17 57 9 52 D 26 29 15 U U 26 29 7 19 13 8 D U 34 
 Mutation * P485L P485L P485L P485L P485L P485L P485L G168R P485L P485L P485L P485L P485L P485L P485L P485L P485L E70Q V100E 
Facial 
features 
Facial dysmorphism                    
Full cheeks                    
Micrognathia                    
Subglottal stenosis                    
Cleft palate/bifid uvula                    
Limbs 
 
Long fingers                    
Ulnar deviation of the 
hands 
                   
Digital and wrist 
contractures 
                   
Under-modelled phalanges, 
metacarpals/metatarsals 
                   
Elbow contractures/ 
dislocated radius 
                   
Broad thumbs/fingers                    
Valgus deformity of the 
feet 
                   
Under-modelled 
metaphyses/diaphyses 
                   
Single palmar creases                    
Pes cavus                    
Cranial and 
neurological 
Intellectual disability                    


















Skull base sclerosis                    
Chiari malformation                    
Cervical vertebral fusion                    
Spine 
Scoliosis                    
Spina bifida occulta                    
Sprengel deformity                    
Urogenital 
system 
Hydronephrosis                    
Urethral stenosis                    
Skin Keloid scars                    
Ocular 
features 
Leucoma corneae                    
Amblyopia                    
Astigmatism                    
Other 
features 
Structural heart defect                    
Growth retardation                    
Undescended testes                    
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